<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Thyroid medication recalled nationwide after tablets found to be 'superpotent': FDA — Live Feed</title><link>https://www.live-feeds.com/feed/thyroid-medication-recalled-nationwide-after-tablets-found-to-be-superpotent-fda</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/thyroid-medication-recalled-nationwide-after-tablets-found-to-be-superpotent-fda/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Vitruvias Therapeutics Recalls 30 mg Thyroid Tablets for Over-Potency</title><link>https://www.live-feeds.com/feed/thyroid-medication-recalled-nationwide-after-tablets-found-to-be-superpotent-fda</link><guid isPermaLink="false">https://www.live-feeds.com/feed/thyroid-medication-recalled-nationwide-after-tablets-found-to-be-superpotent-fda#u53697</guid><pubDate>Tue, 01 Sep 2026 08:25:29 +0000</pubDate><description>The FDA issued a nationwide recall for Vitruvias Therapeutics 30 mg thyroid tablets after lab tests revealed the medication is superpotent. More than 3,600 bottles are affected. The excessive potency poses a risk of triggering hyperthyroidism, with heightened safety concerns for elderly patients and those who are pregnant. Users must check their product and follow safety protocols to prevent side effects linked to overmedication.Why it mattersThyroid medications regulate metabolism and heart rate. Over-potency can lead to toxic levels of thyroid hormone in the bloodstream. This recall targets </description></item>
<item><title>FDA Issues Nationwide Recall for Superpotent Thyroid Tablets</title><link>https://www.live-feeds.com/feed/thyroid-medication-recalled-nationwide-after-tablets-found-to-be-superpotent-fda</link><guid isPermaLink="false">https://www.live-feeds.com/feed/thyroid-medication-recalled-nationwide-after-tablets-found-to-be-superpotent-fda#u49800</guid><pubDate>Thu, 27 Aug 2026 08:50:07 +0000</pubDate><description>The FDA issued an urgent nationwide recall for thyroid medication after tablets were found to be &amp;quot;superpotent.&amp;quot; Vitruvias Therapeutics is recalling 30 mg thyroid tablets because the excessive potency could trigger hyperthyroidism. The recall specifically highlights increased safety risks for pregnant patients and the elderly. Affected users are advised to check their product and follow safety steps to avoid side effects associated with overmedication.Why it mattersThyroid medication regulates metabolism and hormone levels in the body. Superpotent doses can cause the thyroid to become</description></item>
</channel></rss>